Press Release

Intelerad Ranks #1 Best in KLAS for PACS Canada and PACS Asia/Oceania in the 2019 Best in KLAS Global Report

Montreal, Canada – February 4th, 2019 – For the third year in a row since the introduction of the Global PACS category, Intelerad Medical Systems™, a leader in enterprise workflow solutions, is awarded a Best in KLAS recognition, ranking #1 for PACS Canada and PACS Asia/Oceania in the 2019 Best in KLAS: Global Software (Non-US) report.

“Best in KLAS is about raising the bar for healthcare technology,” says Adam Gale, President of KLAS. “It’s providers and payers demanding better performances, usability, and interoperability. Ultimately, Best in KLAS is about giving providers and payers the tools they need to facilitate superior care and improved outcomes.”

As Intelerad continues rapid growth and expansion into the hospital market, the company remains focused on two key areas: innovation and client satisfaction.

In 2018, Intelerad launched new cloud-based solutions, nuage® Disaster Recovery and nuage® Patient Portal, and finalized the acquisition of Clario Medical, the market-leading Clario SmartWorklist cloud company in Seattle.

In addition, Intelerad’s strong focus on customer satisfaction is clearly evident. An impressive 98% of Intelerad clients surveyed by KLAS would buy Intelerad solutions again, according to the KLAS “PACS 2018: Achieving Success from Selection to Go-Live” report, and 98% of customers consider Intelerad part of their long-term plans.

“We are very thankful to our customers for placing us at the top of the PACS solutions providers, ahead of large and well-respected competitors,” said Paul Lepage, CEO of Intelerad. “We are working hard to provide innovative, unparalleled solutions that help our customers deliver superior imaging services and high-quality healthcare to their communities. I am also very proud of the Intelerad team and excited to build on our success throughout 2019.

For more information, please request a demo.

The Best in KLAS report 2019 is available at www.klasresearch.com.